Related Experiment Videos
[Biological markers for Alzheimer disease]
Toshihisa Tanaka1, Kenji Wada, Hidenaga Yamamori
1Department of Psychiatry and Behavioral Science, Osaka University Graduate School of Medicine.
Summary
Earlier Alzheimer disease (AD) diagnosis is crucial for effective treatment. Investigating oxidized proteins in cerebrospinal fluid (CSF) shows promise for differentiating AD from other neurological conditions.
Area of Science:
- Neuroscience
- Biochemistry
- Biomarker Discovery
Context:
- Alzheimer disease (AD) diagnosis requires reliable markers for timely therapeutic intervention.
- Cerebrospinal fluid (CSF) is a valuable biofluid for neurological disease diagnostics.
- Elevated total tau protein in CSF is observed in various neurological conditions, complicating AD differentiation.
Purpose:
- To identify novel diagnostic markers for Alzheimer disease (AD).
- To investigate the role of protein oxidation in AD pathogenesis.
- To develop a method for differentiating AD from other neurological diseases using CSF analysis.
Summary:
- Heat-stable fractions of CSF were analyzed for protein oxidation markers, specifically carbonyl residues.
- Protein oxidation was found to be significantly involved in Alzheimer disease (AD).
- This oxidative stress marker in CSF shows potential for distinguishing AD from other neurodegenerative disorders.
Impact:
- Provides a potential new avenue for early and accurate AD diagnosis.
- May aid clinicians in differentiating AD from conditions like frontotemporal dementia and corticobasal degeneration.
- Highlights the role of oxidative stress in AD, potentially informing future therapeutic strategies.